{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:10:35Z","timestamp":1785381035090,"version":"3.55.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007440","name":"Hans B\u00f6ckler Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011566","name":"Marga und Walter Boll-Stiftung","doi-asserted-by":"publisher","award":["210\\u201306.01-19"],"award-info":[{"award-number":["210\\u201306.01-19"]}],"id":[{"id":"10.13039\/501100011566","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bbi.2024.12.017","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T16:40:06Z","timestamp":1734108006000},"page":"397-408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Sportizumab \u2013 Multimodal progressive exercise over 10\u00a0weeks decreases Th17 frequency and CD49d expression on CD8+ T cells in relapsing-remitting multiple sclerosis: A randomized controlled trial"],"prefix":"10.1016","volume":"124","author":[{"given":"Sebastian","family":"Proschinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergen","family":"Belen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederike","family":"Adammek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit Lea","family":"Schlagheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Rademacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Warnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"56","key":"10.1016\/j.bbi.2024.12.017_b0005","article-title":"Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis","volume":"11","author":"Akg\u00fcn","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2024.12.017_b0010","unstructured":"American College of Sports Medicine. (2013). ACSM\u2019s guidelines for exercise testing and prescription. Lippincott williams & wilkins."},{"issue":"6","key":"10.1016\/j.bbi.2024.12.017_b0015","first-page":"1282","article-title":"Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose","volume":"25","author":"Angelin","year":"2017","journal-title":"High-Lactate Environments. Cell Metab."},{"issue":"2","key":"10.1016\/j.bbi.2024.12.017_b0020","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/brain\/awq354","article-title":"CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis","volume":"134","author":"Annibali","year":"2011","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.bbi.2024.12.017_b0025","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s41577-022-00718-z","article-title":"The immunology of multiple sclerosis","volume":"22","author":"Attfield","year":"2022","journal-title":"Nat. Rev. Immunol"},{"issue":"6","key":"10.1016\/j.bbi.2024.12.017_b0030","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","article-title":"Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances","volume":"20","author":"Bar-Or","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbi.2024.12.017_b0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0895-4356(00)00314-0","article-title":"Adjusting for multiple testing-when and how?","volume":"54","author":"Bender","year":"2001","journal-title":"J. Clin. Epidemiol."},{"issue":"7","key":"10.1016\/j.bbi.2024.12.017_b0040","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1073\/pnas.0914839107","article-title":"Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties","volume":"107","author":"Billerbeck","year":"2010","journal-title":"Proc. Natl. Acad. Sci. u.s.a."},{"issue":"1","key":"10.1016\/j.bbi.2024.12.017_b0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1152\/physiol.00038.2018","article-title":"High-intensity exercise and mitochondrial biogenesis: Current controversies and future research directions","volume":"34","author":"Bishop","year":"2019","journal-title":"Physiology"},{"issue":"5","key":"10.1016\/j.bbi.2024.12.017_b0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical bases of perceived exertion","volume":"14","author":"Borg","year":"1982","journal-title":"Med. Sci. Sports Exerc."},{"key":"10.1016\/j.bbi.2024.12.017_b0055","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2147\/NDT.S114636","article-title":"The use of natalizumab for multiple sclerosis","volume":"13","author":"Brandstadter","year":"2017","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"24","key":"10.1016\/j.bbi.2024.12.017_b0060","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","article-title":"World Health Organization 2020 guidelines on physical activity and sedentary behaviour","volume":"54","author":"Bull","year":"2020","journal-title":"Br. J. Sports Med."},{"issue":"1","key":"10.1016\/j.bbi.2024.12.017_b0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/ana.25927","article-title":"Role of B Cells in Multiple Sclerosis and Related Disorders","volume":"89","author":"Comi","year":"2021","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.bbi.2024.12.017_b0070","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1474-4422(13)70308-9","article-title":"Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): A randomised, double-blind, placebo-controlled, phase 3 trial","volume":"13","author":"Confavreux","year":"2014","journal-title":"Lancet Neurol."},{"issue":"11","key":"10.1016\/j.bbi.2024.12.017_b0075","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","article-title":"The biology of human natural killer-cell subsets","volume":"22","author":"Cooper","year":"2001","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.bbi.2024.12.017_b0080","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1084\/jem.20080397","article-title":"Human interleukin 17-producing cells originate from a CD161+ CD4+ T cell precursor","volume":"205","author":"Cosmi","year":"2008","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bbi.2024.12.017_b0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/1352458507079445","article-title":"Multiple sclerosis and physical exercise: Recommendations for the application of resistance-, endurance- and combined training","volume":"14","author":"Dalgas","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.bbi.2024.12.017_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-019-1002-3","article-title":"Exercise as Medicine in Multiple Sclerosis\u2014Time for a Paradigm Shift: Preventive, Symptomatic, and Disease-Modifying Aspects and Perspectives","volume":"19","author":"Dalgas","year":"2019","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"10","key":"10.1016\/j.bbi.2024.12.017_b0095","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/1097-4598(200010)23:10<1534::AID-MUS9>3.0.CO;2-D","article-title":"Contractile properties and fatigue of quadriceps muscles in multiple sclerosis","volume":"23","author":"De Haan","year":"2000","journal-title":"Muscle & Nerve"},{"key":"10.1016\/j.bbi.2024.12.017_b0100","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/6789276","article-title":"12 Weeks of Combined Endurance and Resistance Training Reduces Innate Markers of Inflammation in a Randomized Controlled Clinical Trial in Patients With Multiple Sclerosis","volume":"2016","author":"Deckx","year":"2016","journal-title":"Mediators Inflamm."},{"issue":"9","key":"10.1016\/j.bbi.2024.12.017_b0105","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nri3871","article-title":"Immunopathology of multiple sclerosis","volume":"15","author":"Dendrou","year":"2015","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.bbi.2024.12.017_b0110","article-title":"Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications","volume":"2016","author":"Dos Passos","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bbi.2024.12.017_b0115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.expneurol.2017.10.008","article-title":"Exercise training attenuates experimental autoimmune encephalomyelitis by peripheral immunomodulation rather than direct neuroprotection","volume":"299","author":"Einstein","year":"2018","journal-title":"Exp. Neurol."},{"issue":"4","key":"10.1016\/j.bbi.2024.12.017_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103033","article-title":"Physical exercise therapy for autoimmune neuroinflammation: Application of knowledge from animal models to patient care","volume":"21","author":"Einstein","year":"2022","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.bbi.2024.12.017_b0125","doi-asserted-by":"crossref","first-page":"12905","DOI":"10.1038\/s41598-017-13376-2","article-title":"S1P1 deletion differentially affects TH17 and Regulatory T cells","volume":"7","author":"Eken","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbi.2024.12.017_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","article-title":"T cells in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"162","author":"Fletcher","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.bbi.2024.12.017_b0135","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/brain\/awaa117","article-title":"Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions","volume":"143","author":"Fransen","year":"2020","journal-title":"Brain"},{"issue":"7559","key":"10.1016\/j.bbi.2024.12.017_b0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature14452","article-title":"TH17 cells transdifferentiate into regulatory T cells during resolution of inflammation","volume":"523","author":"Gagliani","year":"2015","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.bbi.2024.12.017_b0145","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/ni.2730","article-title":"Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH 17-mediated autoimmune neuroinflammation","volume":"14","author":"Garris","year":"2013","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.bbi.2024.12.017_b0150","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nri3041","article-title":"The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease","volume":"11","author":"Gleeson","year":"2011","journal-title":"Nat. Rev. Immunol"},{"issue":"6","key":"10.1016\/j.bbi.2024.12.017_b0155","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1007\/s00415-024-12286-4","article-title":"Persons with multiple sclerosis older than 55years: an analysis from the German MS registry","volume":"271","author":"Goereci","year":"2024","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.bbi.2024.12.017_b0160","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.intimp.2010.08.008","article-title":"Combined exercise training reduces IFN-\u03b3 and IL-17 levels in the plasma and the supernatant of peripheral blood mononuclear cells in women with multiple sclerosis","volume":"10","author":"Golzari","year":"2010","journal-title":"Int. Immunopharmacol."},{"issue":"21","key":"10.1016\/j.bbi.2024.12.017_b0165","doi-asserted-by":"crossref","first-page":"E2973","DOI":"10.1073\/pnas.1524924113","article-title":"Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation","volume":"113","author":"Gross","year":"2016","journal-title":"Proc. Natl. Acad. Sci. u.s.a."},{"key":"10.1016\/j.bbi.2024.12.017_b0170","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3389\/fimmu.2016.00606","article-title":"Regulatory functions of natural killer cells in multiple sclerosis","volume":"7","author":"Gross","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2024.12.017_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-017-0960-9","article-title":"Exercise prescription for patients with multiple sclerosis; potential benefits and practical recommendations","volume":"17","author":"Halabchi","year":"2017","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.bbi.2024.12.017_b0180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-2567.2008.02837.x","article-title":"T helper cell type 1 (Th1), Th2 and Th17 responses to myelin basic protein and disease activity in multiple sclerosis","volume":"125","author":"Hedegaard","year":"2008","journal-title":"Immunol."},{"issue":"3","key":"10.1016\/j.bbi.2024.12.017_b0185","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89160","article-title":"Foxp3 drives oxidative phosphorylation and protection from lipotoxicity","volume":"2","author":"Howie","year":"2017","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.bbi.2024.12.017_b0190","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1172\/JCI63681","article-title":"IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis","volume":"123","author":"Huber","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"7","key":"10.1016\/j.bbi.2024.12.017_b0195","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.molmed.2016.05.007","article-title":"Exercise-Dependent Regulation of NK Cells in Cancer Protection","volume":"22","author":"Idorn","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.bbi.2024.12.017_b0200","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s00415-019-09489-5","article-title":"A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition","volume":"268","author":"Inojosa","year":"2021","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.bbi.2024.12.017_b0205","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/jnnp-2017-317411","article-title":"Cladribine: mechanisms and mysteries in multiple sclerosis","volume":"89","author":"Jacobs","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.12.017_b0210","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2209944120","article-title":"Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound","volume":"120","author":"Janoschka","year":"2023","journal-title":"Proc. Natl. Acad. Sci. u.s.a."},{"key":"10.1016\/j.bbi.2024.12.017_b0215","article-title":"High-intensity interval training reduces neutrophil-to-lymphocyte ratio in persons with multiple sclerosis during inpatient rehabilitation","volume":"1\u20134","author":"Joisten","year":"2020","journal-title":"Mult. Scler. J."},{"issue":"9","key":"10.1016\/j.bbi.2024.12.017_b0220","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/ni0903-815","article-title":"What is trogocytosis and what is its purpose?","volume":"4","author":"Joly","year":"2003","journal-title":"Nat. Immunol"},{"issue":"12","key":"10.1016\/j.bbi.2024.12.017_b0225","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1177\/1352458520915629","article-title":"Exercise and lifestyle physical activity recommendations for people with multiple sclerosis throughout the disease course","volume":"26","author":"Kalb","year":"2020","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.bbi.2024.12.017_b0230","doi-asserted-by":"crossref","DOI":"10.3352\/jeehp.2021.18.17","article-title":"Sample size determination and power analysis using the G*Power software","volume":"18","author":"Kang","year":"2021","journal-title":"J. Educ. Eval. Health Prof."},{"issue":"4","key":"10.1016\/j.bbi.2024.12.017_b0235","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029025","article-title":"Effector T cells in multiple sclerosis","volume":"8","author":"Kaskow","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"3","key":"10.1016\/j.bbi.2024.12.017_b0240","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/ana.21748","article-title":"Preferential recruitment of interferon-\u03b3-expressing TH17 cells in multiple sclerosis","volume":"66","author":"Kebir","year":"2009","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.bbi.2024.12.017_b0245","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.apmr.2016.04.016","article-title":"Rehabilitation in Multiple Sclerosis: A Systematic Review of Systematic Reviews","volume":"98","author":"Khan","year":"2017","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"10.1016\/j.bbi.2024.12.017_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.549842","article-title":"Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring","volume":"11","author":"Khoy","year":"2020","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.bbi.2024.12.017_b0255","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1177\/1352458517722645","article-title":"Can resistance training impact MRI outcomes in relapsing-remitting multiple sclerosis?","volume":"24","author":"Kj\u00f8lhede","year":"2018","journal-title":"Mult. Scler. J."},{"issue":"12","key":"10.1016\/j.bbi.2024.12.017_b0260","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.apmr.2013.07.011","article-title":"Objectively quantified physical activity in persons with multiple sclerosis","volume":"94","author":"Klaren","year":"2013","journal-title":"Arch. Phys. Med. Rehabil."},{"issue":"4","key":"10.1016\/j.bbi.2024.12.017_b0265","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.smim.2013.10.009","article-title":"The plasticity of human Treg and Th17 cells and its role in autoimmunity","volume":"25","author":"Kleinewietfeld","year":"2013","journal-title":"Semin. Immunol."},{"issue":"2","key":"10.1016\/j.bbi.2024.12.017_b0270","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1212\/WNL.0000000000011241","article-title":"Efficacy of High-Intensity Aerobic Exercise on Brain MRI Measures in Multiple Sclerosis","volume":"96","author":"Langeskov-Christensen","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.bbi.2024.12.017_b0275","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jaut.2016.04.003","article-title":"Dysregulation of regulatory CD56bright NK cells\/T cells interactions in multiple sclerosis","volume":"72","author":"Laroni","year":"2016","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.bbi.2024.12.017_b0280","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1038\/s41467-019-13731-z","article-title":"IL-17+ CD8+ T cell suppression by dimethyl fumarate associates with clinical response in multiple sclerosis","volume":"10","author":"L\u00fcckel","year":"2019","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bbi.2024.12.017_b0285","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/eji.202048627","article-title":"Tc17 biology and function: Novel concepts","volume":"50","author":"L\u00fcckel","year":"2020","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.bbi.2024.12.017_b0290","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1002\/eji.200940257","article-title":"CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC","volume":"40","author":"Maggi","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbi.2024.12.017_b0295","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.3389\/fimmu.2018.02819","article-title":"Metabolic, mental and immunological effects of normoxic and hypoxic training in multiple sclerosis patients: A pilot study","volume":"9","author":"M\u00e4hler","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2024.12.017_b0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2020.02.012","article-title":"Natural killer cells in multiple sclerosis: A review","volume":"222","author":"Mimpen","year":"2020","journal-title":"Immunol. Lett."},{"issue":"10","key":"10.1016\/j.bbi.2024.12.017_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102647","article-title":"The role of TH17 cells in multiple sclerosis: Therapeutic implications","volume":"19","author":"Moser","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbi.2024.12.017_b0310","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S1474-4422(17)30281-8","article-title":"Exercise in patients with multiple sclerosis","volume":"16","author":"Motl","year":"2017","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.bbi.2024.12.017_b0315","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ni.3466","article-title":"Immunometabolism of regulatory T cells","volume":"17","author":"Newton","year":"2016","journal-title":"Nat. Immunol"},{"issue":"5","key":"10.1016\/j.bbi.2024.12.017_b0320","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/ana.20859","article-title":"Natalizumab effects on immune cell responses in multiple sclerosis","volume":"59","author":"Niino","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2024.12.017_b0325","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa1014656","article-title":"Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis","volume":"14","author":"O\u2019connor","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"638","key":"10.1016\/j.bbi.2024.12.017_b0330","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abi4632","article-title":"Proinflammatory CD20+ T cells contribute to CNS-directed autoimmunity","volume":"14","author":"Ochs","year":"2022","journal-title":"Sci. Transl. Med"},{"issue":"9","key":"10.1016\/j.bbi.2024.12.017_b0335","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41577-023-00920-7","article-title":"Trogocytosis challenges the cellular specificity of lineage markers and monoclonal antibodies","volume":"23","author":"Ochs","year":"2023","journal-title":"Nat. Rev. Immunol"},{"issue":"2","key":"10.1016\/j.bbi.2024.12.017_b0340","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/10543409408835083","article-title":"Implications of chance baseline differences in repeated measurement designs","volume":"4","author":"Overall","year":"1994","journal-title":"J. Biopharm. Stat."},{"issue":"2","key":"10.1016\/j.bbi.2024.12.017_b0345","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4049\/jimmunol.1400118","article-title":"Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients","volume":"193","author":"Palanichamy","year":"2014","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bbi.2024.12.017_b0350","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jaci.2016.11.045","article-title":"Recognition of viral and self-antigens by TH1 and TH1\/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses","volume":"140","author":"Paroni","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbi.2024.12.017_b0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/sms.12581","article-title":"Exercise as medicine - Evidence for prescribing exercise as therapy in 26 different chronic diseases","volume":"25","author":"Pedersen","year":"2015","journal-title":"Scand. J. Med. Sci. Sports."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2024.12.017_b0360","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jneuroim.2013.10.004","article-title":"Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis","volume":"265","author":"Plantone","year":"2013","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.bbi.2024.12.017_b0365","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: An important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.bbi.2024.12.017_b0370","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2024.12.017_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-0978-3","article-title":"Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties","volume":"14","author":"Prajeeth","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.bbi.2024.12.017_b0380","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029249","article-title":"The evolving mechanisms of action of glatiramer acetate","volume":"9","author":"Prod\u2019homme","year":"2019","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.bbi.2024.12.017_b0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-019-1544-7","article-title":"Influence of combined functional resistance and endurance exercise over 12 weeks on matrix metalloproteinase-2 serum concentration in persons with relapsing-remitting multiple sclerosis - a community-based randomized controlled trial","volume":"19","author":"Proschinger","year":"2019","journal-title":"BMC Neurol."},{"key":"10.1016\/j.bbi.2024.12.017_b0390","article-title":"The effect of exercise on regulatory T cells: A systematic review of human and animal studies with future perspectives and methodological recommendations","volume":"27","author":"Proschinger","year":"2021","journal-title":"Exerc. Immunol. Rev."},{"issue":"6","key":"10.1016\/j.bbi.2024.12.017_b0395","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1007\/s00415-021-10935-6","article-title":"Fitness, physical activity, and exercise in multiple sclerosis: a systematic review on current evidence for interactions with disease activity and progression","volume":"269","author":"Proschinger","year":"2022","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.bbi.2024.12.017_b0400","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s00421-023-05251-y","article-title":"Intensity- and time-matched acute interval and continuous endurance exercise similarly induce an anti-inflammatory environment in recreationally active runners: focus on PD-1 expression in Tregs and the IL-6\/IL-10 axis","volume":"123","author":"Proschinger","year":"2023","journal-title":"Eur. J. Appl. Physiol."},{"issue":"10","key":"10.1016\/j.bbi.2024.12.017_b0405","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1177\/13524585221079200","article-title":"Investigating the potential disease-modifying and neuroprotective efficacy of exercise therapy early in the disease course of multiple sclerosis: The Early Multiple Sclerosis Exercise Study (EMSES)","volume":"28","author":"Riemenschneider","year":"2022","journal-title":"Mult. Scler. J."},{"issue":"7","key":"10.1016\/j.bbi.2024.12.017_b0410","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301619R","article-title":"Beyond muscles: Investigating immunoregulatory myokines in acute resistance exercise \u2013 A systematic review and meta-analysis","volume":"38","author":"Ringleb","year":"2024","journal-title":"FASEB Journal"},{"key":"10.1016\/j.bbi.2024.12.017_b0415","volume":"eLife, 11","author":"Rodr\u00edguez-Lorenzo","year":"2022","journal-title":"Single-Cell Profiling Reveals Periventricular CD56bright NK Cell Accumulation in Multiple Sclerosis."},{"key":"10.1016\/j.bbi.2024.12.017_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103931","article-title":"Immunological consequences of cladribine treatment in multiple sclerosis: A real-world study","volume":"64","author":"Rolfes","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"13","key":"10.1016\/j.bbi.2024.12.017_b0425","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1177\/13524585231204453","article-title":"The MoxFo initiative - Mechanisms of action: Biomarkers in multiple sclerosis exercise studies","volume":"29","author":"Rosenkranz","year":"2023","journal-title":"Mult. Scler. J."},{"issue":"51","key":"10.1016\/j.bbi.2024.12.017_b0430","doi-asserted-by":"crossref","first-page":"25800","DOI":"10.1073\/pnas.1915309116","article-title":"Anti-CD20 therapy depletes activated myelin-specific CD8+ T cells in multiple sclerosis","volume":"116","author":"Sabatino","year":"2020","journal-title":"Proc. Natl. Acad. Sci. u.s.a."},{"key":"10.1016\/j.bbi.2024.12.017_b0435","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0197-2456(02)00242-8","article-title":"The method of minimization for allocation to clinical trials: a review","volume":"23","author":"Scott","year":"2002","journal-title":"Control. Clin. Trials"},{"issue":"11","key":"10.1016\/j.bbi.2024.12.017_b0440","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202210262","article-title":"Trojan Horse Nanocapsule Enabled In Situ Modulation of the Phenotypic Conversion of Th17 Cells to Treg Cells for the Treatment of Multiple Sclerosis in Mice","volume":"35","author":"Shi","year":"2023","journal-title":"Adv. Mater."},{"issue":"6","key":"10.1016\/j.bbi.2024.12.017_b0445","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1007\/s12035-016-0014-0","article-title":"Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption","volume":"54","author":"Souza","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.bbi.2024.12.017_b0450","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1212\/NXI.0000000000000076","article-title":"Reduction of CD8+ T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate","volume":"2","author":"Spencer","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.bbi.2024.12.017_b0455","first-page":"53","article-title":"Treatment of multiple sclerosis - success from bench to bedside","volume":"15","author":"Tintore","year":"2019","journal-title":"Nat. Rev. Immunol"},{"issue":"10","key":"10.1016\/j.bbi.2024.12.017_b0460","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1093\/brain\/awl213","article-title":"Polyclonal expansion of regulatory T cells interferes with effector cell migration in a model of multiple sclerosis","volume":"129","author":"Tischner","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2024.12.017_b0465","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ene.12883","article-title":"Disease-modifying treatments for multiple sclerosis - a review of approved medications","volume":"23","author":"Torkildsen","year":"2016","journal-title":"Eur J Neurol"},{"issue":"5","key":"10.1016\/j.bbi.2024.12.017_b0470","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/brain\/awy069","article-title":"T helper 17.1 cells associate with multiple sclerosis disease activity: Perspectives for early intervention","volume":"141","author":"Van Langelaar","year":"2018","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.bbi.2024.12.017_b0475","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molmed.2009.12.003","article-title":"Disturbed regulatory T cell homeostasis in multiple sclerosis","volume":"16","author":"Venken","year":"2010","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.bbi.2024.12.017_b0485","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/brain\/awy301","article-title":"Proinflammatory CD20+ T cells in the pathogenesis of multiple sclerosis","volume":"142","author":"von Essen","year":"2019","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.bbi.2024.12.017_b0490","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200140","article-title":"Intrathecal CD8+CD20+ T Cells in Primary Progressive Multiple Sclerosis","volume":"10","author":"von Essen","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.bbi.2024.12.017_b0495","doi-asserted-by":"crossref","unstructured":"Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R. A., Robertson, N., La Rocca, N., Uitdehaag, B., van der Mei, I., Wallin, M., Helme, A., Angood Napier, C., Rijke, N., & Baneke, P. (2020). Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult. Scler. J., 26(14), 1816\u20131821. https:\/\/doi.org\/10.1177\/1352458520970841.","DOI":"10.1177\/1352458520970841"},{"issue":"7740","key":"10.1016\/j.bbi.2024.12.017_b0500","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41586-018-0846-z","article-title":"Mitochondrial complex III is essential for suppressive function of regulatory T cells","volume":"565","author":"Weinberg","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbi.2024.12.017_b0505","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jaci.2015.10.035","article-title":"Physical exercise modulates the homeostasis of human regulatory T cells","volume":"137","author":"Weinhold","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbi.2024.12.017_b0510","article-title":"The neuropathobiology of multiple sclerosis","volume":"1\u201321","author":"Woo","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbi.2024.12.017_b0515","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jneuroim.2018.12.005","article-title":"Effects of moderate- versus high- intensity swimming training on inflammatory and CD4 + T cell subset profiles in experimental autoimmune encephalomyelitis mice","volume":"328","author":"Xie","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.bbi.2024.12.017_b0520","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00109-019-01761-5","article-title":"Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis","volume":"97","author":"Yadav","year":"2019","journal-title":"J. Mol. Med."},{"issue":"12","key":"10.1016\/j.bbi.2024.12.017_b0525","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1177\/1352458517728342","article-title":"High-intensity interval exercise improves cognitive performance and reduces matrix metalloproteinases-2 serum levels in persons with multiple sclerosis: A randomized controlled trial","volume":"24","author":"Zimmer","year":"2017","journal-title":"Mult. Scler. J."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124007475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124007475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T07:08:24Z","timestamp":1739084904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159124007475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":104,"alternative-id":["S0889159124007475"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2024.12.017","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sportizumab \u2013 Multimodal progressive exercise over 10\u00a0weeks decreases Th17 frequency and CD49d expression on CD8+ T cells in relapsing-remitting multiple sclerosis: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2024.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}